The Platelet IIb/IIIa Inhibitor Abciximab as Adjunctive Therapy in Carotid Stenting of Potential Thrombotic Lesions
- 1 October 1999
- journal article
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 12 (5) , 355-361
- https://doi.org/10.1111/j.1540-8183.1999.tb00259.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockadeThe Lancet, 1998
- Current global status of carotid artery stent placementCatheterization and Cardiovascular Diagnosis, 1998
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Angioplasty and Stenting for Restenosis After Carotid EndarterectomyStroke, 1996
- Integrelin for emergency coronary artery stentingJournal of the American College of Cardiology, 1996
- Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis StudyJAMA, 1995
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994
- Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid StenosisNew England Journal of Medicine, 1991
- Prospective Study of the Effectiveness and Durability of Carotid EndarterectomyMayo Clinic Proceedings, 1990
- Measurements of acute cerebral infarction: a clinical examination scale.Stroke, 1989